Adjuvant chemotherapy guidance for pT1–3N0–1 breast cancer patients with HR(+), HER2(−) subtype: a cohort study based on the SEER database

BACKGROUND: Although the results of gene testing can guide early breast cancer patients with hormone receptor (HR)(+), human epidermal growth factor receptor 2 (HER2)(−) to decide whether they need chemotherapy (CHT), there are still many patients worldwide whose problems cannot be resolved by genet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Nan, Qiu, Juanjuan, Xu, Li, Wang, Yu, Zhang, Jia, Xie, Yanyan, Lv, Qing, Du, Zhenggui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756223/
https://www.ncbi.nlm.nih.gov/pubmed/35071473
http://dx.doi.org/10.21037/atm-21-5937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756223/
https://www.ncbi.nlm.nih.gov/pubmed/35071473
http://dx.doi.org/10.21037/atm-21-5937

Ejemplares similares